Welcure Drugs & Pharmaceuticals Ltd — Updates, 14-05-2025: Company Update

Welcure Drugs & Pharmaceuticals Ltd. has announced a board meeting approving proposals to expand its business scope and increase its authorised share capital from Rs. 116 Cr to Rs. 186 Cr, subject to shareholders’ approval. The company plans to add new business activities including trading various goods, real estate development, construction, property management, consulting services, and dealing in jewellery and precious metals. This strategic move aims to diversify operations and enhance growth potential, signaling an expanded operational footprint beyond pharmaceuticals for shareholders.